Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

Daniel Keizman, Maya Ish-Shalom, Roberto Pili, Hans Hammers, Mario A. Eisenberger, Victoria Sinibaldi, Ben Boursi, Natalie Maimon, Maya Gottfried, Henry Hayat, Avivit Peer, Svetlana Kovel, Avishay Sella, Raanan Berger, Michael A. Carducci